Back
Piedmont Lithium Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
26
PLL
Piedmont Lithium
Last Price:
$8.96
Seasonality Move:
9.52%
Sell
2
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
26
Piedmont Lithium (PLL)
is a Sell
Is Piedmont Lithium a Buy, Sell or Hold?
-
The current Piedmont Lithium [PLL] share price is $8.94. The Score for PLL is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
PLL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PLL Stock Price Chart
What is Piedmont Lithium's stock price today?
-
The Piedmont Lithium share price today is $8.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLL is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $40.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
PLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 39.07 | Sell |
Chaikin Money Flow: | -6601 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.72 - 11.34) | Sell |
Bollinger Bands (100): | (8.31 - 12.65) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 22.69 | Sell |
Chaikin Money Flow: | -2576687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.5 - 57.26) | Sell |
Bollinger Bands (100): | (51.08 - 57.64) | Sell |
PLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.25 | Sell |
20-day SMA: | 9.53 | Sell |
50-day SMA: | 11.28 | Sell |
200-day SMA: | 11.15 | Sell |
8-day EMA: | 9.26 | Sell |
20-day EMA: | 9.72 | Sell |
50-day EMA: | 10.51 | Sell |
200-day EMA: | 13.46 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.44 | Sell |
20-day SMA: | 52.35 | Sell |
50-day SMA: | 55.3 | Sell |
200-day SMA: | 51.01 | Sell |
8-day EMA: | 48.54 | Sell |
20-day EMA: | 51.52 | Sell |
50-day EMA: | 53.69 | Sell |
200-day EMA: | 49.87 | Sell |
Piedmont Lithium Earnings Growth & PLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and a decrease next year of $0.46 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Piedmont Lithium Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |